On March 2, 2015, Dr. Andrew Mearns Spragg, General Manager of Jellagen, a medical technology company in the United Kingdom, and Ecz. Selçuk Haydanlı visited TÜBİTAK MAM KE in order to develop a joint project within the scope of EU Horizon 2020. Within the scope of the visit, Dr. Serdar Sezer, Deputy Director of TÜBİTAK MAM KE Institute, provided information about the projects carried out/planned in the medical field and the EU Horizon 2020 calls with private sector participation. Following the presentations of the projects open to possible cooperation, the company representatives visited TÜBİTAK MAM KE laboratories and received information about the relevant studies.
Share this News
For questions and suggestionsContact Us
Most Recent
TBTK.MAM.2025-01 and TBTK.MAM.2025-02 Job Announcements Interview Results are Announced
The results of the interviews held between 07/05/2025 - 16/06/2025 for the job postings of TÜBİTAK Marmara Research Center (MAM) TBTK.MAM.2025-01 and TBTK.MAM.2025-02...
A Critical Threshold is Crossed in Turkey's Defense and Communication Technologies
Strategic projects carried out in cooperation with TÜBİTAK, the Presidency of Defense Industries (SSB) and the leading stakeholders of the sector, are the first of its kind in Turkey's defense, CBRN (Chemical, Biological,...
TBTK.MAM.ADAY.2025-1 numbered Job Announcement Interview Results are Announced
The results of the interviews held between 23-27/10/2025 for the job announcement of TÜBİTAK Marmara Research Center (MAM) TBTK.MAM.ADAY.2025-1 have been announced. TUBITAK Marmara...
National Water Management System ATHOM Dissemination Training Completed
The second phase of the ATHOM project, developed by TÜBİTAK MAM to manage Turkey's largest water basins, concluded with a comprehensive training program for DSİ personnel and dam operators, attended by over 200 participants.